Connect with us

Health

Nigeria to Administer Rotavirus Vaccine to Children in Abuja, 19 States

Published

on

rotavirus vaccine

By Modupe Gbadeyanka

Children in Nigeria will now receive the rotavirus vaccine, giving them protection against rotavirus infections, the leading cause of severe diarrhoea in young children worldwide.

This has been made possible through a partnership with Gavi, the Vaccine Alliance (Gavi), WHO, UNICEF and other partners.

The vaccine would be administered by the government in its routine immunisation programme through the National Primary Health Care Development Agency (NPHCDA).

Childhood diarrhoea is the third leading cause of childhood mortality in Nigeria, accounting for 15 per cent of all deaths in children aged under five.

The vaccine will initially be available in 19 states and the FCT, starting with zones with lower vaccination coverage, and will later be rolled out to the remaining 17 states – with the aim to reach 7 million children within the first 12 months. The rotavirus vaccine will be administered orally to infants at 6, 10 and 14 weeks of age.

“This introduction is a major milestone in the push to protect more Nigerian children against vaccine-preventable diseases. The rotavirus-related disease is the leading cause of severe diarrhoea in young children worldwide, and a key contributor to childhood mortality in Nigeria,” said Thabani Maphosa, Managing Director of Country Programmes for Gavi, the Vaccine Alliance. “We commend the continued commitment of the Government of Nigeria and will work with all partners to support this vital programme, which will reach children with this life-saving vaccine.”

In order to reach so many children quickly, partners have planned to roll out several service delivery strategies such as daily vaccination in select sites as well as mobile sessions to reach hard-to-reach rural communities.

Vaccination will also be integrated with other primary health care services and diarrhoea prevention strategies such as hand washing, exclusive breastfeeding and provision of quality water and sanitation facilities.

Protecting young children through this vaccine also decreases rates of rotavirus infection in unimmunised and elderly populations. Vaccination will also help reduce the use of antibiotics, which are often – ineffectively – prescribed to treat rotavirus infections, thus helping stem the rise of antibiotic resistance.

Concerted efforts by NPHCDA and partners to strengthen health systems over recent years have allowed the country to gradually increase COVID-19 vaccine coverage, while at the same time maintaining routine immunisation as part of its Optimized SCALES 2.0 strategy.

The latest WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) indicate that Nigeria is one of few countries that maintained gains in routine childhood immunisation in 2021 at a time when the COVID-19 pandemic negatively impacted essential health services around the world.

Modupe Gbadeyanka is a fast-rising journalist with Business Post Nigeria. Her passion for journalism is amazing. She is willing to learn more with a view to becoming one of the best pen-pushers in Nigeria. Her role models are the duo of CNN's Richard Quest and Christiane Amanpour.

Click to comment

Leave a Reply

Health

Agusto Foresees More Foreign Investments in Nigeria’s Healthcare System

Published

on

Nigeria's healthcare system

By Adedapo Adesanya

Global research firm, Agusto & Co, has forecast that an increased foreign interest will drive growth in Nigeria’s healthcare system, especially through the acquisition and establishment of health facilities in the medium term.

Agusto said in a report that these foreign investments would help the country bridge the healthcare infrastructure deficit estimated at $82 million.

According to data, Nigeria is largely underfunded in terms of its health system and, as a result, is faced with a significant infrastructure gap.

The industry is currently challenged by outbound medical tourism, deteriorating medical infrastructure, low government budget allocation, and poor compensation for public healthcare workers, all of which have prompted many skilled medical practitioners to relocate overseas in search of better employment opportunities.

In addition, brain drain is also contributing to this as approximately 2,000 doctors leave the country each year, and at least 266 Nigerian doctors were licensed in the United Kingdom between June and July 2022, according to the National Medical Association (NMA).

Nigeria has also not been playing its part, with the health sector receiving only about 4 per cent (N546.98 billion) and 5 per cent (N724.6 billion) of the total budgetary allocation in Nigeria’s 2021 and 2022 budgets. This undershoots the 15 per cent expected by the World Health Organisation (WHO) and African  Union (AU).

Agusto noted that the emergence of COVID-19 in 2020 saw an increase in diagnostic facilities and, albeit insufficiently, an increase in public investments in the health sector with efforts from the Central Bank of Nigeria (CBN).

Despite this, there remains more to be done, especially with the country’s large population facing a high burden of communicable and non-communicable diseases, resulting in many people constantly seeking treatment.

Foreign investors have found the Nigerian healthcare system to be an attractive investment opportunity, and in 2021, the healthcare industry attracted around $2.3 million in foreign direct investments (FDI).

For instance, in February 2021, Evercare Group, through its emerging market health fund, established Evercare Hospital Lekki, a 165-bed multispecialty tertiary care facility.

Agusto predicts that the industry’s contribution to gross domestic product (GDP) will reach N480.6 billion by 2022 from N470.5 billion, based on the country’s high birth rate and the spread of communicable diseases as well as other common ailments such as malaria and respiratory tract infection.

It also expects that a lower rate of outbound medical tourism, as a result of the naira’s continued depreciation, will boost the industry’s contribution to GDP in the medium term.

Continue Reading

Health

Delta-9 THC: A Guide to its Effects

Published

on

Delta-9 THC

Delta-9 THC has been the most studied cannabinoid. THC has been proven to have pain-relieving and anti-nausea properties. However, research on its neuroprotective and depression-fighting qualities is still ongoing.

INDUCES EUPHORIA

Many generations of cannabis users have embraced the plant’s mood-enhancing properties, Delta-9 THC. Intoxication with cannabis is unlike any other substance, as it absorbs the mind and body into feelings of joy, relaxation and delight. These euphoric feelings can have a lasting impact on our system. A 2016 study about aggression and cannabis consumption revealed that cannabis decreased aggressive feelings, while alcohol increased them.

ANTINAUSEA PROPERTIES

The well-documented anti-nausea properties of Delta-9 THC are well documented. This was one the first medical benefits that were identified in cannabis. It was established in the 1970s, and 80s. Since 1984, high-thc cannabis strains were prescribed to patients with cancer. It was originally used to treat radiotherapy-induced nausea. Patients today still benefit from THC. The only FDA-approved THC medication is those that treat nausea in patients with cancer.

STIMULATE

The munchies, or an increased hunger feeling after cannabis consumption, is one of the most common side effects. This can be beneficial for people with low appetite. In 2018, a study found that THC increases appetite hormones, including ghrelin (and leptin), and does not affect insulin levels. This is a positive sign for obesity and eating disorders.

ADDICTION TREATMENT

Although it may seem counterproductive to swap a beer for a preroll, THC can help decrease alcoholism and other drug addictions. Legalizing THC does not only reduce alcohol sales but THC intake increases an individual’s chances of success in treatment for opioid addiction. A 2017 study of animals showed that cannabis administration reduced heroin consumption.

NEUROPROTECTIVE PROPERTIES

Delta-9 THC, like other cannabinoids works with the endocannabinoid systems to promote homeostasis. This cannabinoid acts in neuronal cultures of the brain, as an antioxidant. It also encourages neurogenesis (creating more neurons). Delta-9 THC is able to reduce muscle spasms for patients with multiple sclerosis, and slow down the nervous system degradation for patients with Parkinson’s. This is a significant development for patients with neurodegenerative conditions such as Parkinson’s disease.

ANTIDEPRESSANT

A 2020 study showed that almost all 1,819 patients experienced temporary relief from depressive symptoms following cannabis consumption. The authors point out that other studies have shown that cannabis consumption can cause depression. However, this is dependent on the individual and may vary from person to person. If it works for your situation, you can use mother nature’s resources.

Delta-9 THC – How Do You Get it?

THC, like all cannabinoids comes from cannabigerolic (CBGa), which is the “mother” cannabinoids. From CBGa, the compound undergoes an enzymatic reaction called cannabidiolic acid synthase (CBDAS) to become THCa or tetrahydrocannabinolic acid. The heat process of decarboxylation causes THCa to break down to form Delta-9 THC.

Can Delta-9 get you high?

Yes, Delta-9, the most prominent cannabinoid responsible intoxicating and psychoactive effects of cannabis, will make you feel “high”.

What Does Delta-9 Do in the body?

Delta-9 THC is absorbed into your lungs through the gastrointestinal tract. It then enters the bloodstream via your bloodstream. Depending on how the drink was taken, it may interact with your Endocannabinoid System to create intoxicating “high”.

The Endocannabinoid System

The receptors of the endocannabinoid systems are located throughout the body. They help maintain homeostasis by improving biological functions. The ECS is essential for our health.

CB1 receptors are the primary receptors of the ECS. CB2 is the secondary. The brain, nervous system, liver and spinal cord are the main locations of CB1 receptors. CB1 can bind with both the natural cannabinoids and Delta-9 THC.

The delta 9 products that carried at Pure CBD Now come from the same top-rated, reputable brands that you’ve become familiar with over the years.

Continue Reading

Health

Heritage Bank Gives Succour to Sickle Cell Persons in Nigeria

Published

on

sickle cell persons

By Modupe Gbadeyanka

A financial institution in Nigeria, Heritage Bank Plc, has partnered with a non-profit organisation, Gail Sickle Initiative, to ameliorate the burden of sickle cell persons in the country.

This is part of the lender’s corporate social initiatives aimed at providing support to people in need, especially sickle cell patients.

An Executive Director at Heritage Bank, Ms Osepiribo Ben-Willie, disclosed that it has become of concern to the bank to help alleviate the burden of over 40 million Nigerians, who are healthy carriers of the sickle cell gene and the 150,000 children born with the disorder.

According to her, this is by far the largest burden of sickle cell disorder around the world, especially in Nigeria, and most of these children die in childhood from lack of access to early diagnosis and proper care.

“At Heritage Bank, health is a priority; that is why we want to continue partnering and supporting the NGO, Gail Sickle Initiative on welfare support, early detection and improved treatment and proper care,” she said.

Ms Ben-Willie further affirmed that Heritage Bank, in partnership with Gail Sickle Initiative, is synergizing to create significant awareness and support for individuals affected by the disease.

On her part, the convener of Gail Sickle Initiative, Ms Oluwafemi Ajayi, disclosed that with the support from Heritage Bank, the NGO has gone beyond its support to her members, whom she refers to as winning warriors, to supporting and donating to people living with the sickle cell disease across the country.

According to her, as an organisation that supplies supplements to winning warriors, the Gail Sickle Initiative partnered with Heritage Bank and with the funds provided went beyond the organisation’s members and reached out to other winning warriors who have no parental support and to those in various hospital to give them supplements and offset the bill of some who were unable to pay their bills.

Ms Ajayi further stated that Sickle Cell disorder poses various challenges to the carriers like health challenges, stigmatisation, and economic challenge, amongst others.

She said the Gail Sickle Initiative focused on how to cover every aspect of these challenges by birthing the Sicklepreneur, this aids the warriors to be trained so they can acquire relevant skills and equip themselves to be independent. Therefore, apart from trying to eradicate sickle cell disease, they ensure that the stigmatisation label on the warriors does not result in depression for them.

She encouraged other corporate organisations to learn from Heritage Bank’s sterling example to the winning warriors by supporting the initiative and further contributed to the back-to-school project with relevant items donated.

Continue Reading

Latest News on Business Post

Like Our Facebook Page

%d bloggers like this: